Underwriting discounts and commissions(1) Any representation to the contrary is a criminal offense. Securities and Exchange Commission, or the SEC, nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. See Risk Factors beginning on page 22 to readĪbout factors you should consider before buying shares of our common stock. Investing in our common stock involves risks. See Management≼ontrolled Company Exemption. As a result, we will be a controlled company within the meaning of the corporate governance standards of NASDAQ. will continue to own 75.2% (or 73.6% if the underwriters exercise in full their option to purchase additional shares of our common stock) of the shares eligible to vote in the election of ourĭirectors. After the completion of this offering, fundsĪdvised by Apax Partners LLP and Apax Partners, L.P. Of the Securities Act of 1933, as amended, or the Securities Act, and, as such, we have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. We are an emerging growth company as defined in Section 2(a)(19) Market, or NASDAQ, under the symbol ∼DLA. We have applied to list our common stock on the NASDAQ Global Select We expect that the initial public offering price of our common stock will be between $16.00 and $18.00 per share. Offering, there has been no public market for our common stock. We are offering 14,705,882 shares of common stock. Initial public offering of common stock of Candela Medical, Inc. Subject to completion, dated October 19, 2021 Securities in any jurisdiction where the offer and sale is not permitted. This preliminary prospectus is not an offer to sell these securities nor a solicitation of an offer to buy these These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. The information in this preliminary prospectus is not complete and may be changed. The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shallįile a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this Registration Statement shall becomeĮffective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine. The Registrant previously paid $9,270 in connection with a prior filing of the Registration Statement. Promulgated under the Securities Act of 1933, as amended. SeeĮstimated solely for the purpose of calculating the registration fee in accordance with Rule 457(a) Includes 2,205,882 shares of common stock that the underwriters have the option to purchase. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition periodįor complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. See the definitions of large accelerated filer, accelerated filer smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act: Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-acceleratedįiler, a smaller reporting company or an emerging growth company. ☐Īmendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. Registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act The Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of (Name, address, including zip code, and telephone number, including area code, of registrants agent for service)Īpproximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement is declared effective. (Address, including zip code, and telephone number, including area code, of registrants principal executive offices) (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on October 19, 2021
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |